After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that Relay Therapeutics to Participate in Three Upcoming Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, RLAY falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Relay Therapeutics Inc is $1.09B. A total of 0.68 million shares were traded on the day, compared to an average of 1.09M shares.
In the most recent transaction, Bergstrom Donald A sold 765 shares of RLAY for 7.70 per share on Mar 27 ’24. After the transaction, the President, R&D now owns 530,113 company shares. In a previous transaction on Mar 27 ’24, Catinazzo Thomas sold 348 shares at 7.70 per share. RLAY shares that Chief Financial Officer owns now total 341,498.
Among the insiders who sold shares, Adams Brian disposed of 348 shares on Mar 27 ’24 at a per-share price of $7.70. This resulted in the Chief Legal Officer holding 327,390 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 298 shares at $7.70 per share on Mar 27 ’24. Company shares held by the insider now total 514,679.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, RLAY has a high of $19.23 and a low of $5.95.
As of this writing, RLAY has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.63 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.54 in the last quarter, which was 34.90% higher than expectations of -$0.83.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $5.90, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.67.
